 FT. MYERS, FL ACCESSWIRE October 13, 2021 NeoGenomics, Inc. NASDAQ:NEO, a leading provider of cancer-focused genetic testing and global contract research services, announced today that it plans to release its third quarter 2021, financial results on Thursday, November 4, 2021. The Company has scheduled a webcast and conference call to discuss their third quarter results on Thursday, November 4, 2021 at 8:30 AM EDT. 